Key result
Antihypertensive prescriptions reach only 14% of youth with primary hypertension, linked to older age and obesity.
Why the study?
Higher neighborhood deprivation is linked to hypertension diagnosis in youth, but its association with antihypertensive therapy prescription among insured youth with primary hypertension was unknown.
What factors are associated with antihypertensive therapy prescription among insured youth with primary hypertension?
Cross-Sectional (n=1,145)
What factors are associated with antihypertensive therapy prescription among insured youth with primary hypertension?
Antihypertensive therapy prescription rates in youth with primary hypertension are low (14%) and are associated with older age, obesity, and longer Medicaid coverage, but not area deprivation.
Answers are grounded in this paper and cite their sources.
Low prescription rates signal potential gaps in pediatric hypertension care; this Level 4 cross-sectional study leaves open causal pathways and intervention targets.
BACKGROUND: Higher neighborhood deprivation is associated with hypertension diagnosis in youth. In this study, we assess if there is an association between neighborhood deprivation and antihypertensive therapy prescription among insured youth with a primary hypertension diagnosis. METHODS: Using a retrospective cross-sectional design, we assessed the proportion of youth with a diagnosis of primary hypertension prescribed antihypertensive therapy. We evaluated the proportion of youth prescribed antihypertensive therapy and compared prescribing patterns by area deprivation index (ADI), age, sex, obesity diagnosis, race, ethnicity, and duration of Medicaid coverage. RESULTS: Of the 65,452 non-pregnant Delaware Medicaid recipients, 8-18 years of age, 1,145 (1.7%) had an International classification of diseases (ICD)-9/ICD-10 diagnosis of primary hypertension; 165 of the 1,145 (14%) were prescribed antihypertensive therapy. Factors associated with a greater odds of prescription by multivariable logistic regression were age, obesity diagnosis, and duration of Medicaid full benefit coverage. Odds of antihypertensive therapy prescription did not vary by race, ethnicity, or ADI. CONCLUSIONS: Antihypertensive therapy prescription rates are poor despite national guideline recommendations. Among youth receiving Delaware Medicaid between 2014 and 2019, prescription proportions were highest among youth of older age, with an obesity diagnosis, and among youth with longer duration of Medicaid benefit coverage. Although high area deprivation has been shown to be associated with the diagnosis of hypertension, high vs. low area deprivation was not associated with greater antihypertensive therapy prescription among youth with primary hypertension. Our finding of a mismatch between hypertension diagnosis and antihypertensive therapy prescription highlights a potential disparity in antihypertensive therapy prescription in youth.
No takes yet. Share an insight, caveat, or question.
Baker‐Smith et al. (2023) conducted a cross-sectional in Primary hypertension (n=1,145). Antihypertensive therapy prescription was evaluated on Proportion of youth prescribed antihypertensive therapy. Among youth with primary hypertension, only 14% were prescribed antihypertensive therapy, with higher prescription odds associated with older age, obesity, and longer Medicaid coverage.
Synapse has enriched 10 related papers. Consider them for comparative context: